109 related articles for article (PubMed ID: 14575366)
1. Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program registry: has outcome improved? (United States).
Barnholtz-Sloan JS; Severson RK; Vaishampayan U; Hussain M
Cancer Causes Control; 2003 Sep; 14(7):681-5. PubMed ID: 14575366
[TBL] [Abstract][Full Text] [Related]
2. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.
Pienta KJ; Demers R; Hoff M; Kau TY; Montie JE; Severson RK
Urology; 1995 Jan; 45(1):93-101; discussion 101-2. PubMed ID: 7817485
[TBL] [Abstract][Full Text] [Related]
3. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
4. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
5. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
6. Black-white differences in survival from late-stage prostate cancer.
Polednak AP
Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in survival of female breast cancer in the Detroit metropolitan area.
Simon MS; Severson RK
Cancer; 1996 Jan; 77(2):308-14. PubMed ID: 8625239
[TBL] [Abstract][Full Text] [Related]
8. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
[TBL] [Abstract][Full Text] [Related]
11. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
Schwartz KL; Severson RK; Gurney JG; Montie JE
Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area.
Demers RY; Swanson GM; Weiss LK; Kau TY
Arch Intern Med; 1994 Jun; 154(11):1211-6. PubMed ID: 8203988
[TBL] [Abstract][Full Text] [Related]
13. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Steele CB; Li J; Huang B; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
[TBL] [Abstract][Full Text] [Related]
16. Race, socioeconomic status, and breast cancer treatment and survival.
Bradley CJ; Given CW; Roberts C
J Natl Cancer Inst; 2002 Apr; 94(7):490-6. PubMed ID: 11929949
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time.
Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Obstet Gynecol; 2013 Nov; 209(5):468.e1-468.e10. PubMed ID: 23891626
[TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
19. Race, prostate cancer survival, and membership in a large health maintenance organization.
Robbins AS; Whittemore AS; Van Den Eeden SK
J Natl Cancer Inst; 1998 Jul; 90(13):986-90. PubMed ID: 9665146
[TBL] [Abstract][Full Text] [Related]
20. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
